• BioMendics, LLC is a startup company currently located in the REDIzone a small business accelerator located at the Northeast Ohio Medical University (NEOMED).  BioMendics specializes in topical drug development for the treatment of wounds, burns, psoriasis and other skin related applications.  

  • Our lead product TegaSure is a patent pending combination of liquid crystal biomimetic substances that cut wound healing times in half while being non-immunogenic and less irritating to skin than baby shampoo.  
  • The market for wound care products in 2012 was over $7 billion USD and is expected to reach over $11 billion USD by 2021 with CAGR of 25-60% with significant expansion in Asian markets. TegaSure can easily attain scale-up manufacturing with low cost raw materials and a highly competitive manufacturing price.

Click below to learn more about TegaSure.

 

TegaSure  →